NEC Risk Reduced in 2nd Clinical Study Using 100% Human Milk Diet for Preemies

This week, Prolacta Bioscience announced a new clinical study just published by the Journal of Pediatrics clearly demonstrating that 100% exclusive human milk based diet for pre-term infants reduces chances of surgery associated with the life threatening disease necrotizing enterocolitis (NEC).  This reinforces a study in 2009 and points to a new standard of care for these infants.

Even ...

Continue Reading →

BayCare Health Systems & Prolacta Bioscience Set Pace for Premature Infant 100% Breastmilk Diet

Partnership with Prolacta Bioscience (PilmerPR client) Ensures a Safe, Standardized, and Steady Supply of Pasteurized Donor Milk to Meet Feeding Needs of Premature Infants throughout BayCare Health System

CLEARWATER, Fla., July 11, 2013 /PRNewswire-USNewswire/ — BayCare Health System has announced a partnership with Prolacta Bioscience to ensure a safe, standardized, and steady supply of pasteurized donor breast milk to meet the feeding requirements of their hospitalized premature infant population. Under the partnership, Prolacta will manage the breast milk donor qualification ...

Continue Reading →

ABC News: Local Moms Keep Preemies Alive

From time to time I get to be involved in a terrific cause. Doing Public Relations for Milk for Wishes Milk Bank & Helping Hands Milk Bank, both sponsored by Prolacta is one such cause. Prolacta produces the only human milk-based fortifier for severely premature infants in neonatal intensive care units (NICU).

Here’s a story we facilitated in South Carolina that shows why Prolacta and breast milk donation matter.

ABC Columbia television FULL STORY.

Continue Reading →